These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33911167)

  • 21. Cardiovascular Outcomes and Mortality After Bariatric Surgery in Patients With Nonalcoholic Fatty Liver Disease and Obesity.
    Krishnan A; Hadi Y; Alqahtani SA; Woreta TA; Fang W; Abunnaja S; Szoka N; Tabone LE; Thakkar S; Singh S
    JAMA Netw Open; 2023 Apr; 6(4):e237188. PubMed ID: 37027156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hospital admission with non-alcoholic fatty liver disease is associated with increased all-cause mortality independent of cardiovascular risk factors.
    Mann JP; Carter P; Armstrong MJ; Abdelaziz HK; Uppal H; Patel B; Chandran S; More R; Newsome PN; Potluri R
    PLoS One; 2020; 15(10):e0241357. PubMed ID: 33108366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Body Weight Variability and Risk of Cardiovascular Outcomes and Death in the Context of Weight Loss Intervention Among Patients With Type 2 Diabetes.
    Kaze AD; Santhanam P; Erqou S; Ahima RS; Bertoni AG; Echouffo-Tcheugui JB
    JAMA Netw Open; 2022 Feb; 5(2):e220055. PubMed ID: 35179583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Disease, Cancer, and Mortality Among People With Type 2 Diabetes and Alcoholic or Nonalcoholic Fatty Liver Disease Hospital Admission.
    Wild SH; Walker JJ; Morling JR; McAllister DA; Colhoun HM; Farran B; McGurnaghan S; McCrimmon R; Read SH; Sattar N; Byrne CD;
    Diabetes Care; 2018 Feb; 41(2):341-347. PubMed ID: 29167212
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic Fatty Liver Disease and Sarcopenia Are Independently Associated With Cardiovascular Risk.
    Han E; Lee YH; Kim YD; Kim BK; Park JY; Kim DY; Ahn SH; Lee BW; Kang ES; Cha BS; Han KH; Nam HS; Heo JH; Kim SU
    Am J Gastroenterol; 2020 Apr; 115(4):584-595. PubMed ID: 32141917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obesity and Weight Gain Are Associated With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
    Kim Y; Chang Y; Cho YK; Ahn J; Shin H; Ryu S
    Clin Gastroenterol Hepatol; 2019 Feb; 17(3):543-550.e2. PubMed ID: 30012432
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alcoholic and Nonalcoholic Fatty Liver Disease and Liver-Related Mortality: A Cohort Study.
    Chang Y; Cho YK; Cho J; Jung HS; Yun KE; Ahn J; Sohn CI; Shin H; Ryu S
    Am J Gastroenterol; 2019 Apr; 114(4):620-629. PubMed ID: 30694866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data.
    Lee J; Jo G; Park D; Jun HJ; Bae JH; Shin MJ
    Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986234
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD).
    Golabi P; Otgonsuren M; de Avila L; Sayiner M; Rafiq N; Younossi ZM
    Medicine (Baltimore); 2018 Mar; 97(13):e0214. PubMed ID: 29595666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Association between Nonalcoholic Fatty Liver Disease and Stroke: Results from the Korean Genome and Epidemiology Study (KoGES).
    Yang YJ; Jung MH; Jeong SH; Hong YP; Kim YI; An SJ
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33371282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic value of non-alcoholic fatty liver disease for predicting cardiovascular events in patients with diabetes mellitus with suspected coronary artery disease: a prospective cohort study.
    Ichikawa K; Miyoshi T; Osawa K; Miki T; Toda H; Ejiri K; Yoshida M; Nanba Y; Yoshida M; Nakamura K; Morita H; Ito H
    Cardiovasc Diabetol; 2021 Jan; 20(1):8. PubMed ID: 33413363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease.
    Haflidadottir S; Jonasson JG; Norland H; Einarsdottir SO; Kleiner DE; Lund SH; Björnsson ES
    BMC Gastroenterol; 2014 Sep; 14():166. PubMed ID: 25260964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease progression rates to cirrhosis and progression of cirrhosis to decompensation and mortality: a real world analysis of Medicare data.
    Loomba R; Wong R; Fraysse J; Shreay S; Li S; Harrison S; Gordon SC
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1149-1159. PubMed ID: 32372515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term glycemic variability on incident cardiovascular disease and mortality in subjects without diabetes: A nationwide population-based study.
    Yu JH; Han K; Park S; Lee DY; Nam GE; Seo JA; Kim SG; Baik SH; Park YG; Kim SM; Kim NH; Choi KM
    Medicine (Baltimore); 2019 Jul; 98(29):e16317. PubMed ID: 31335679
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of NAFLD on the Incidence of Cardiovascular Diseases in a Primary Care Population in Germany.
    Labenz C; Huber Y; Michel M; Nagel M; Galle PR; Kostev K; Schattenberg JM
    Dig Dis Sci; 2020 Jul; 65(7):2112-2119. PubMed ID: 31797186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sarcopenia modifies the associations of nonalcoholic fatty liver disease with all-cause and cardiovascular mortality among older adults.
    Sun X; Liu Z; Chen F; Du T
    Sci Rep; 2021 Aug; 11(1):15647. PubMed ID: 34341404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cardiovascular disease in patients with fatty liver disease as defined from the metabolic dysfunction associated fatty liver disease or nonalcoholic fatty liver disease point of view: a retrospective nationwide claims database study in Japan.
    Yoneda M; Yamamoto T; Honda Y; Imajo K; Ogawa Y; Kessoku T; Kobayashi T; Nogami A; Higurashi T; Kato S; Hosono K; Saito S; Nakajima A
    J Gastroenterol; 2021 Nov; 56(11):1022-1032. PubMed ID: 34601620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up.
    Ekstedt M; Hagström H; Nasr P; Fredrikson M; Stål P; Kechagias S; Hultcrantz R
    Hepatology; 2015 May; 61(5):1547-54. PubMed ID: 25125077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.